AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$1.12B |
| 2 |
Walt Disney
DIS
|
+$880M |
| 3 |
ILOW
AB International Low Volatility Equity ETF
ILOW
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$716M |
| 5 |
United Rentals
URI
|
+$667M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$1.12B |
| 2 |
NVIDIA
NVDA
|
+$971M |
| 3 |
Edwards Lifesciences
EW
|
+$971M |
| 4 |
CrowdStrike
CRWD
|
+$671M |
| 5 |
Adobe
ADBE
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.33% |
| 2 | Healthcare | 15.32% |
| 3 | Consumer Discretionary | 10.78% |
| 4 | Financials | 9.65% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
OptimizeRx
OPRX
$120M
| $209K | ﹤0.01% |
27,050
| – | – |
|
|
DCBO
3027
Docebo
DCBO
$513M
| $209K | ﹤0.01% |
3,494
+233
| +7% | +$9.54K |
|
3028
Applied Optoelectronics
AAOI
$7.87B
| $208K | ﹤0.01% |
14,510
-22,198
| -60% | -$230K |
|
3029
Park Aerospace
PKE
$783M
| $208K | ﹤0.01% |
15,932
| – | – |
|
|
MGIC
3030
DELISTED
Magic Software Enterprises
MGIC
| $207K | ﹤0.01% |
4,680
| – | – |
|
3031
Willis Lease Finance
WLFC
$1.68B
| $207K | ﹤0.01% |
+4,170
| New | +$137K |
|
3032
Aquestive Therapeutics
AQST
$468M
| $206K | ﹤0.01% |
41,290
+10
| +0% | +$39 |
|
3033
Oil-Dri
ODC
$1.44B
| $205K | ﹤0.01% |
+5,940
| New | +$193K |
|
3034
Corbus Pharmaceuticals
CRBP
$171M
| $205K | ﹤0.01% |
9,920
+2,710
| +38% | +$139K |
|
3035
Entrada Therapeutics
TRDA
$235M
| $204K | ﹤0.01% |
12,770
+2,550
| +25% | +$40.2K |
|
3036
Granite Ridge Resources
GRNT
$611M
| $204K | ﹤0.01% |
34,300
-3,720
| -10% | -$23.8K |
|
3037
Bowman Consulting
BWMN
$457M
| $204K | ﹤0.01% |
8,460
+570
| +7% | +$15.8K |
|
3038
Bioventus
BVS
$837M
| $199K | ﹤0.01% |
16,670
+5,210
| +45% | +$45K |
|
3039
Coherus Oncology
CHRS
$228M
| $196K | ﹤0.01% |
188,410
| – | – |
|
3040
GrowGeneration
GRWG
$89.5M
| $195K | ﹤0.01% |
91,770
| – | – |
|
|
GRAL
3041
GRAIL Inc
GRAL
$2.92B
| $195K | ﹤0.01% |
14,169
-888
| -6% | -$13.5K |
|
3042
Absci
ABSI
$1.31B
| $195K | ﹤0.01% |
50,970
-510
| -1% | -$2.03K |
|
3043
Sigma Lithium
SGML
$1.12B
| $194K | ﹤0.01% |
+15,680
| New | +$171K |
|
3044
E.W. Scripps
SSP
$276M
| $193K | ﹤0.01% |
86,047
| – | – |
|
3045
Pure Cycle
PCYO
$258M
| $190K | ﹤0.01% |
17,620
+770
| +5% | +$7.89K |
|
3046
Ooma
OOMA
$566M
| $189K | ﹤0.01% |
16,590
| – | – |
|
3047
Kodiak Sciences
KOD
$2.67B
| $187K | ﹤0.01% |
71,470
| – | – |
|
3048
Monte Rosa Therapeutics
GLUE
$1.95B
| $186K | ﹤0.01% |
35,140
+2,360
| +7% | +$11.9K |
|
|
CRON
3049
Cronos Group
CRON
$1.07B
| $185K | ﹤0.01% |
84,598
| – | – |
|
3050
Sight Sciences
SGHT
$281M
| $184K | ﹤0.01% |
29,280
+1,820
| +7% | +$12.2K |
|
Similar funds
AllianceBernstein's Q3 2024 Portfolio in Review
As of Q3 2024, AllianceBernstein held 3,302 positions worth $298B, up 3.8% from $287B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.2%. AllianceBernstein opened 69 new positions and exited 70, leaving the 3,302-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q3 2024 buy was AB International Low Volatility Equity ETF: 21,418,062 shares worth $784M.
- AllianceBernstein added most to Applied Materials in Q3 2024, an estimated $1.12B increase.
- AllianceBernstein's biggest Q3 2024 reduction was Intuitive Surgical, cutting an estimated $1.12B.
- AllianceBernstein fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2024, selling an estimated $154M.
- AllianceBernstein's ten largest holdings make up 28% of its $298B portfolio in Q3 2024.
- AllianceBernstein opened 69 new positions and closed 70 in Q3 2024.
- AllianceBernstein's portfolio value rose 3.8% quarter-over-quarter to $298B.
Based on AllianceBernstein's 13F filing for Q3 2024, filed 14 Nov 2024.